Eye Correction Centre Competitors

Alder Hey Children's NHS Foundation Trust is one of Europe’s biggest and busiest children’s hospitals, treating more than 450,000 children and young people every year. It is one of only four stand-alone paediatric trusts in the UK and is staffed by more than 4,000 employees. We offer 20 specialist services including being the designated national centre for head and face surgery and a Centre of Excellence for children with cancer, heart, spinal and brain disease. It is a teaching hospital and trains 550 medical and 400 nursing students each year. Alder Hey hosts the UK Medicines for Children Research Network (MCRN) with a Department of Health grant worth £22m and is also the lead centre for the Cheshire, Merseyside and North Wales MCRN. It leads the field in paediatric pharmacovigilance, being recently awarded the only paediatric NHS programme grant (£2m) for work in this area. In 2015 Alder Hey became Alder Hey in the Park. The new hospital is built in Springfield Park, next door to the old site. The new Alder Hey sits right in the heart of the park, surrounded by green space which can be seen from almost every window.

We’re a leader in eye care, particularly in lens and laser eye surgery. In fact, we’re Europe’s No.1 laser eye surgery provider, with locations in 7 countries including Germany and Croatia. We’re the UK’s leading complete eye care provider too. Our 128 stores and clinics offer exceptional service and outstanding visual solutions, from designer glasses to high-quality contact lenses and from lens, cataract and laser eye surgery to LipiFlow dry eye treatment. We also understand that the people at the heart of our business make us what we are. Our culture is incredibly important. The values we work towards are Patient & Customer Focus One Team Delivering Results Trusted Excellence Across all areas of Optical Express we’re committed to helping our employees learn and develop to deliver service excellence. In the last few years we’ve made additional investment into transformational change. It’s had a hugely positive impact, on our patients’ experience and on our colleagues in their day-to-day roles. For optometrists, it’s an exciting time to be at Optical Express. No matter what stage of the career ladder you’re on, there’s no better place in which to develop clinically. We believe that our CET-approved professional development courses and clinical support systems are second to none. Our partnership with Glasgow Caledonian University offers our optometrists the opportunity to qualify as Independent Prescribers, fully funded by us. We also invest in continued training for team members across Optical Express, with a number of colleagues currently working towards qualifications in Marketing, Learning & Development and Personnel Practice. We believe that Optical Express has a responsibility to give back, and we want to make a difference on a worldwide scale, too. We continue to partner with international charity Sightsavers, working to eliminate avoidable blindness in developing countries, and support charities at home including The STV Appeal and Cash for Kids.

Newmedica is one of England’s leading independent providers of NHS-funded ophthalmology services, delivering expert eyecare that helps protect and preserve sight. Working in partnership with the NHS, GPs, and local opticians, we care for over 230,000 NHS and private patients each year across 30+ locations, offering quick access to advanced treatment in modern, community-based clinics. Backed by a dedicated team of 1,200+ employees, we’re proud to deliver short wait times, outstanding outcomes, and compassionate care with 99% of patients recommending us and 100% saying they were treated with dignity and respect. We're thrilled to say that following an independently conducted survey of Newmedica colleagues to tell us what it’s like to work here, we've been certified as a Great Place to Work for the second year running. The feedback has directly contributed to Newmedica being listed among the UK’s top 50 Best Workplaces™ for 2025.